Haematology

Last updated: 26th Jul 2024

Explore our range of haematology learning resources, including expert opinion, recent guideline updates, information on emerging treatments, and more.

Medical conditions

Microscopic tissue slice with dyed cells showing amyloidosis

AL amyloidosis

Expert interviews, case studies, trials, and more

A digital image of the inside of a human artery with visible blood cells and clotting

Coagulation and Haemorrhagic Disorders

Containing relevant Learning Zones, guidelines, trials and news.

Close up of a lumbar puncture; spinal needle; white gloves

Haematological and Bone Marrow Cancers

Containing relevant Learning Zones, guidelines, trials and news.

HIV

Containing relevant Learning Zones, guidelines, trials and news.

Red and white blood cells within the body, representing blood cancers

Leukaemia

Containing relevant Learning Zones, guidelines, trials and news.

Lymphoma

Containing relevant Learning Zones, guidelines, trials and news.

Venous thromboembolism

Containing relevant Learning Zones, guidelines, trials and news.

Independent resources

AL amyloidosis

Containing relevant Learning Zones, guidelines, trials and news.

Leukaemia

Containing relevant Learning Zones, guidelines, trials and news.

Resources created with our funding partners

Learning Zone

Albumin in fluid management

Explore expert-led content discussing guidelines for fluid management, clinical trial data and emerging uses of albumin in this Learning Zone.

Learning Zone

Fibrinogen Deficiency in Bleeding Learning Zone

Fibrinogen is an essential coagulation factor in the blood clotting cascade. The importance for fibrinogen in normal haemostasis is highlighted in patients of inherited fibrinogen deficiencies who display coagulopathies such as excessive bleeding and thrombolytic events.

Learning Zone

Oral Anticoagulation Reversal Learning Zone

This educational resource is designed to help healthcare professionals diagnose, manage and treat bleeding in patients taking anticoagulants.

Related news and insights

Drug news

European Commission approves Durveqtix (fidanacogene elaparvovec), a one-time gene therapy for adults with hemophilia B

Pfizer Inc. announced that the European Commission (EC) has granted conditional marketing authorization for Durveqtix (fidanacogene elaparvovec), a gene therapy for the treatment of severe and moderately severe hemophilia B (congenital factor IX deficiency) in adult patients without a history of factor IX inhibitors and without detectable antibodies to variant AAV serotype Rh74

1 mins

Drug news

Positive topline results from phase III study of giroctocogene fitelparvovec a hemophilia A gene therapy candidate

Pfizer Inc. announced positive topline results from the Phase III AFFINE study (NCT04370054) evaluating giroctocogene fitelparvovec, an investigational gene therapy for the treatment of adults with moderately severe to severe hemophilia A.

3 min

Drug news

Positive data demonstrating 2-drug regimen shows Dovato (dolutegravir/lamivudine) is as effective as 3-drug regimen Biktarvy (bictegravir/emtricitabine]/tenofovir alafenamide fumarate) for maintenance therapy of HIV-1

GSK plc announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, has shared 48-week findings from the PASO DOBLE (GeSIDA 11720 study), the largest head-to-head, phase IV randomised clinical trial (RCT) investigating the 2-drug regimen Dovato (dolutegravir/lamivudine [DTG/[3TC]) compared to the 3-drug regimen Biktarvy (bictegravir/emtricitabine]/tenofovir alafenamide fumarate [BIC/FTC/TAF]) for the treatment of HIV-1 in people who are virologically suppressed and who could benefit from treatment optimisation

3 min

See all news

Welcome:

Updates in your area
of interest

Articles your peers
are looking at

Bookmarks
saved

Days to your
next event

Related Guidelines

Guideline

Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma)

The mature or peripheral T-cell neoplasms are a heterogeneous group of rare disorders arising from clonal proliferation of mature post-thymic lymphocytes.

1 mins

Guideline

Guideline for the diagnosis and management of marginal zone lymphomas: A British Society of Haematology Guideline

The objective of this guideline is to provide healthcare professionals with clear guidance on the diagnosis and management of patients with marginal zone lymphoma (MZL).

1 min

Guideline

The management of newly diagnosed large B-cell lymphoma: A British Society for Haematology Guideline

This BSH guideline summarises the recommended initial investigation and first-line management of large B-cell lymphoma (LBCL).

1 min

See all guidelines